𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New p53-based anti-cancer therapeutic strategies

✍ Scribed by Klas G Wiman

Publisher
Springer US
Year
1998
Tongue
English
Weight
738 KB
Volume
15
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Current strategies for the development o
Current strategies for the development of peptide-based anti-cancer therapeutics
✍ Corina Borghouts; Christian Kunz; Bernd Groner πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 288 KB

## Abstract The completion of the human genome sequence and the development of new techniques, which allow the visualisation of comprehensive gene expression patterns, has led to the identification of a large number of gene products differentially expressed in tumours and corresponding normal tissu

Head and neck cancer: Response to p53-ba
Head and neck cancer: Response to p53-based therapeutics
✍ Jackie Nemunaitis; John Nemunaitis πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 97 KB

## Abstract Limited options are available for patients with advanced stage head and neck cancer. The p53 gene is known as the β€œguardian of the genome.” Mutations of the p53 gene predispose to carcinogenesis. The p53 mutations are common in head and neck cancer. Replacement of p53 gene function in p

Restoration of p53 function: A new thera
Restoration of p53 function: A new therapeutic strategy to induce tumor regression?
✍ Naiara Beraza; Christian Trautwein πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 119 KB

Although cancer arises from a combination of mutations in oncogenes and tumour suppressor genes, the extent to which tumour suppressor gene loss is required for maintaining established tumours is poorly understood. p53 is an important tumour suppressor that acts to restrict proliferation in response